Mitochondrial proteome: altered cytochrome c oxidase subunit levels in prostate cancer. - Wikidata - awgldk - TriplyDB

Mitochondrial proteome: altered cytochrome c oxidase subunit levels in prostate cancer.

Mitochondrial proteome: altered cytochrome c oxidase subunit levels in prostate cancer.

http://www.wikidata.org/entity/Q30981892

about

Mitochondrial Dysfunction in Cancer and Neurodegenerative Diseases: Spotlight on Fatty Acid Oxidation and Lipoperoxidation Products High-throughput sequencing in mitochondrial DNA research Oxidative stress induces mitochondrial DNA damage and cytotoxicity through independent mechanisms in human cancer cells Proteomics and mass spectrometry for cancer biomarker discovery A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine Hybrid dysfunction and physiological compensation in gene expression.Cancer phototherapy via selective photoinactivation of respiratory chain oxidase to trigger a fatal superoxide anion burst Genes that may modulate longevity in C. elegans in both dauer larvae and long-lived daf-2 adults Preliminary study of proteomic shift from normal to premalignant laryngeal lesions and to laryngeal squamous cell carcinoma.Serum markers of apoptosis decrease with age and cancer stage.mtDNA mutations increase tumorigenicity in prostate cancer.Quantitative protein expression analysis of CLL B cells from mutated and unmutated IgV(H) subgroups using acid-cleavable isotope-coded affinity tag reagents.Paraquat exposure and Sod2 knockdown have dissimilar impacts on the Drosophila melanogaster carbonylated protein proteome A microarray method for identifying tumor antigens by screening a tumor cDNA expression library against cancer sera.Serum-dependent transcriptional networks identify distinct functional roles for H-Ras and N-Ras during initial stages of the cell cycle Autophagy inhibitor LRPPRC suppresses mitophagy through interaction with mitophagy initiator Parkin.Spatiotemporal expression profiling of proteins in rat sciatic nerve regeneration using reverse phase protein arrays.The use of next generation sequencing technology to study the effect of radiation therapy on mitochondrial DNA mutation.Changes in the in vitro activity of platinum drugs when administered in two aliquots.Challenges facing the development and use of protein chips to analyze the phosphoproteome.Building the mitochondrial proteome.Cancer cell growth and survival as a system-level property sustained by enhanced glycolysis and mitochondrial metabolic remodeling Altered metabolism and mitochondrial genome in prostate cancer.Mitochondrial DNA as a potential tool for early cancer detection.Cytochrome c oxidase is activated by the oncoprotein Ras and is required for A549 lung adenocarcinoma growth Mitochondria and cancer: Warburg addressed.Expression and clinical significance of cytochrome c oxidase subunit IV in colorectal cancer patients.Loss of COX5B inhibits proliferation and promotes senescence via mitochondrial dysfunction in breast cancer Application of physicochemically modified silicon substrates as reverse-phase protein microarrays Mitochondrial DNA mutations and breast tumorigenesis.Mammalian mitochondrial proteomics: insights into mitochondrial functions and mitochondria-related diseases.Energy matters: mitochondrial proteomics for biomedicine.Regulation of mitochondrial metabolism: yet another facet in the biology of the oncoprotein Bcl-2.Targeting proteomics to investigate metastasis-associated mitochondrial proteins.Variable slope normalization of reverse phase protein arrays.High expression of COX5B is associated with poor prognosis in breast cancer.Elevated levels of mitochondrion-associated autophagy inhibitor LRPPRC are associated with poor prognosis in patients with prostate cancer.Pro-oxidant treatment of human prostate carcinoma (DU145) induces autoschizis cell death: autophagosomes build up out of injured endomembranes and mitochondria.Protective effects of piperine against copper-ascorbate induced toxic injury to goat cardiac mitochondria in vitro.Expression of mitochondrial genes MT-ND1, MT-ND6, MT-CYB, MT-COI, MT-ATP6, and 12S/MT-RNR1 in colorectal adenopolyps.

P2860

Q26767051-888C5DDB-BE41-4AC7-8E7E-5A15F9146D56 Q27008856-1953335B-5C2E-4CF6-B03F-F3530F2AC480 Q27010269-B17065BB-8FA3-4FF7-967B-823D2DE9DF9B Q28766969-B5A727E3-A1E9-4892-BE01-A3A4E9781334 Q29547303-7B776939-447C-4E99-A259-DE3450C9CB57 Q30870960-4F93215D-B987-4979-A63F-ED5B6081C82E Q31134503-74653527-194A-449A-89F9-22B717721DBE Q33286458-CBB7E1E3-9420-4211-AB24-423E98FBD773 Q33372384-FAFD3B7E-1D84-4FA0-B20F-F298B0DE37C9 Q33588768-CF5F59D2-72CE-432B-BF8B-E357686B650E Q33757050-4DC300D1-2D1B-40ED-A84B-4B3BA48AA4BC Q34452722-BA56EEE3-95EA-4B3D-8334-65AE00BE08AB Q34687410-50EE4DC7-08AA-42F3-AE07-52454AB35CFA Q34817494-FD95DF62-337A-4A46-8BCB-CA7AE6AE8241 Q34964571-BC1B65BA-55DE-4A9F-B1EC-5F470064DB3E Q35145158-6771DCD5-9A9A-4D98-84AA-4323D40EEE39 Q35809020-52DD7460-E3F7-4EE6-B8F9-E6C928295A86 Q35968154-D8DB8985-48DE-4F04-B56C-4F8F954417A5 Q36114723-2E9DF368-E897-4E57-A71C-E235ADF3F327 Q36227928-8AE9DADD-3B72-406A-A756-3E75D14991E1 Q36227948-B160CE8B-C641-4D13-BFEF-C3C4621C675A Q36228895-BF938BB1-5B30-44FE-80A9-A5E934E8E691 Q36361069-4533ABF6-38A4-41C2-86D1-77D45495CDBA Q36388046-DDE79BE0-36D4-428F-93FE-260886A48CF0 Q36536104-FD87A73D-6486-4332-84D3-3B5A621DD79A Q36547748-82741925-3FF7-4F27-9B36-EFCCBE4F9701 Q36582356-713A27CC-A1B4-4C21-A539-BB9D67E6B815 Q36685411-836D43E0-7780-4CA6-9C0A-E0C89EDCCE85 Q37219904-0B139311-D773-4691-9F3C-A7E0AC75624F Q37477802-1B0BFDCA-C07C-438E-81B7-02FD09E0EA22 Q37763932-69E71A8F-E3AF-4CFA-AA51-E0A78C32503E Q37829412-63B7371C-2F64-4C63-A6F8-3C9BE9B77E66 Q37864354-7BCCDB74-8A54-4C35-9BB1-048D705352D5 Q38034442-5AFB66E6-4854-4385-9DE7-B09C2C769025 Q38545364-05A4880C-5691-4DDD-84D6-47FA1B7CAE85 Q38673586-74BB903B-AEEF-4E60-9580-AB32BF2B7CA3 Q38685838-66882D96-EBDD-4398-B0BB-80A67C0C855B Q38982040-AA79C8FD-2585-42E9-A014-54D369205522 Q39154358-0E80312B-F36A-4FAB-A378-5464207D455A Q39662667-DC7DFFA8-3B80-4E1D-81B1-406C8C605D00

P2860

Mitochondrial proteome: altered cytochrome c oxidase subunit levels in prostate cancer.

http://www.wikidata.org/entity/Q30981892

description

2003 nî lūn-bûn

@nan

2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Mitochondrial proteome: altered cytochrome c oxidase subunit levels in prostate cancer.

@ast

Mitochondrial proteome: altered cytochrome c oxidase subunit levels in prostate cancer.

@en

type

label

Mitochondrial proteome: altered cytochrome c oxidase subunit levels in prostate cancer.

@ast

Mitochondrial proteome: altered cytochrome c oxidase subunit levels in prostate cancer.

@en

prefLabel

Mitochondrial proteome: altered cytochrome c oxidase subunit levels in prostate cancer.

@ast

Mitochondrial proteome: altered cytochrome c oxidase subunit levels in prostate cancer.

@en

P1433

Q30981892-94C1ED0B-DF42-4B6E-A97D-8E9DABDDA79D

P1476

Q30981892-2BB58EE0-6243-4CDE-AAA8-6F2F7460E3DD

P2093

Q30981892-0F450B07-0A03-484D-8572-F48DB4669147

Q30981892-227F4DBE-2D76-43A2-8AA6-4ADF11551BD6

Q30981892-439322C9-F11A-4988-80BF-B6DCD1A0B242

Q30981892-7C4DFC35-E917-4019-BD61-9A6DD9BFA3B1

Q30981892-82509A28-89CE-44C0-9E37-6B2CCBBC344A

Q30981892-B217AA8B-AB8F-41D1-B395-3BFA7816B813

Q30981892-BD4DE174-3E4B-4538-BFA7-3DE44726BF77

Q30981892-C23DD671-D060-44DB-ADAD-C01C3376E266

Q30981892-CFCB6686-03FA-45C0-A48A-F8D684C444F6

Q30981892-FE911849-206A-4877-A019-A50B5E4741D6

P304

Q30981892-3FE3F089-A149-45BE-90F8-1F920A05D0D2

P31

Q30981892-0EA0C15F-ED43-4E1A-AD9D-C9293DDA5C36

P356

Q30981892-C515038E-4F2D-43D9-9799-017D03585D32

P433

Q30981892-53CCD002-BA5F-45D9-861E-A613F106599B

P478

Q30981892-532070C9-D57B-4B10-B4CD-71981966DFAF

P577

Q30981892-FD3CCB5B-D0A6-4693-8E6C-EBF613852031

P5875

Q30981892-831DDB1D-73C7-4FEA-873C-3B646330450E

P698

Q30981892-0CB2FFD0-4F5C-449D-BB9C-6F17D4299204

P356

P1433

P1476

Mitochondrial proteome: altered cytochrome c oxidase subunit levels in prostate cancer.

@en

P2093

Cloud P Paweletz

http://www.w3.org/2001/XMLSchema#string

Elise C Kohn

http://www.w3.org/2001/XMLSchema#string

Emanuel F Petricoin

http://www.w3.org/2001/XMLSchema#string

John W Gillespie

http://www.w3.org/2001/XMLSchema#string

Lance A Liotta

http://www.w3.org/2001/XMLSchema#string

Lu Charboneau

http://www.w3.org/2001/XMLSchema#string

Michael R Emmert-Buck

http://www.w3.org/2001/XMLSchema#string

Paul C Herrmann

http://www.w3.org/2001/XMLSchema#string

Valerie S Calvert

http://www.w3.org/2001/XMLSchema#string

Verena E Bichsel

http://www.w3.org/2001/XMLSchema#string

P304

1801-1810

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PMIC.200300461

http://www.w3.org/2001/XMLSchema#string

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2003-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10567456

http://www.w3.org/2001/XMLSchema#string

P698

12973739

http://www.w3.org/2001/XMLSchema#string